PD-1 (27-41) – Immunology – Antigens/Epitotes/Pools/Librairies

PD-1 (27-41) peptide is derived from the programmed cell death-1 (PD-1) which interacts with its ligand, PD-L1 to regulate immune homeostasis. PD-1 and its ligand PD-L1 are critical in regulating T cell activation, tolerance and immuno-pathology. PD-1 is an immune checkpoint and guards against autoimmunity through two mechanisms. First, it promotes apoptosis of antigen-specific T-cells in lymph nodes. Second, it reduces apoptosis in regulatory T cells. Several types of cancer cells overexpress PD-L1 in order to escape from the PD-1/PD-L1 immuno-surveillance mechanism. Consequently PD-1 inhibitors and PD-L1 inhibitors could be used as a therapeutic in the treatment of cancers.

 

Technical specification

 KD20 peptide Sequence : H-SPDRPWNPPTFSPAL-NH2
 KD20 peptide MW : 1.679.8 g/mol
 KD20 peptide Purity : > 95%
 KD20 peptide Counter-Ion : TFA Salts
Peptide library synthesis KD20 peptide Delivery format : Lyophilized

Price

 

Product Size Price €
Price $
CRB1000340-0.5 mg 0.5 mg 141 € 113 $
CRB1000340-1 mg 1 mg 193 € 154 $
CRB1000340-
CRB1000340-
CRB1000340-

For Bulk Orders